Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I like your jokes. So far from the truth!
What I like as well is that they ended the year with $41 million cash compared to $34million at the end of 2014
"Commenting on fourth quarter accomplishments, David A. Dodd, Chairman, President and Chief Executive Officer of the Company, stated, “Our progress during the fourth quarter was truly astounding. As we began the quarter, we faced the prospect of massive dilution from the exercise of warrants that had very unfavorable terms and a capital structure that challenged our ongoing operations and our ability to raise further funding. We ended the quarter with a cleaned-up capital structure and a successful, significant capital raise on favorable terms. A tremendous amount of difficult work during the quarter made this successful turn-around possible. We now have the resources to complete the Phase 3 studies of both Zoptrex™ and Macrilen™"
Try start reading!
They have sufficient cash to bring Macrilen and Zoptrex to the market. It is good news.
HH: "Excluding onetime transaction and integration costs we expect to be EBITDA positive on a run rate basis exiting 2015, and this trend is expected to continue into 2016."
Transcript from their latest conference call, which was at their Q3 announcement.
Earnings and CC Tuesday premarket.
"Excluding onetime transaction and integration costs we expect to be EBITDA positive on a run rate basis exiting 2015, and this trend is expected to continue into 2016."
Transcript from their latest conference call, which was at their Q3 announcement.
Tuesday premarket.
Last6 months:11 institutions increased their positions totalling 3,594,000 shares
Goldman Sachs, Citigroup and Gugenheim capital took a position in HH.
The last 6 months there have been at least 6 insider buys worth 5,775,000 shares.
After hours: .183/share!!!! +30%
http://www.nasdaq.com/symbol/hh/after-hours
Last trading day before the earnings and CC premarket next Tuesday.
Tech is great.But too short on cash.that means dilution. Since we want to invest (this is Wall Street) we are not throwing away our money. My advice: stay out until they have proved to have sufficient cash and when the dilution is over. For now: sell or go short.
It seems there is a lot of institutional buying going on. They're doing all they can to surpress the rise in share price b/c they know it has been a great quarter and great quarters to come the next years.
HH:Hooper Holmes (NYSE MKT: HH) today announced that it will release 2015 fourth quarter financial results before the market opens on Tuesday, March 29, 2016. The Company will host a conference call on Tuesday, March 29, 2016 at 7:30 a.m. CT (8:30 a.m. ET).
Fourth Quarter Financial Release Date and Conference Call Information
http://ih.advfn.com/p.php?pid=nmona&article=70853404&symbol=HH
Thank you
HH:Holmes's Chief Financial Officer just declared owning 106,967 shares of Hooper Holmes
http://www.conferencecalltranscripts.org/4/summary/?id=2542812
Holmes's Chief Financial Officer just declared owning 106,967 shares of Hooper Holmes
http://www.conferencecalltranscripts.org/4/summary/?id=2542812
Just put a buy target at $.16. If you are bothered to pay $100 more than that is sad.
It is a sign they're expanding their operations. That's what they want to do to meet their goal to turn cash flow positive by the end of this year and to get 100 million dollar in annual sales in 4-5 years.
This is a very, very good sign.
19 new jobs available at Hooper Holmes. That's what I call a bullish sign!
http://www.indeed.com/cmp/Hooper-Holmes/jobs
.18 nearing and then .51 as the next stop
About to cross the 200MA at $.18/share. If we succeed next stop is $.51/share.
Hooper Holmes (HH)Health care stock. Listed on NYSE. Is going to be cash flow positive in 2016. More than 100 years of experience and very ambitious to have an annual run rate of $100m in sales the next 4-5 years. Price target for 2016 : $0.51
Sentiment: buy for short and long term"
Very important sentence.If you can hold this for 3years, HH will be worth at least 4-5dollar/share
Wednesday's volume was het highest in +3years. And PPS+9%
I would say at least $1/share EOY if cash flow positive. At this moment I think there are funds accumulating.
'Cash flow positive by the end of this year and $100m annual sales projected in 3-4 years
A company with more than 100 years of experience, listed on NYSE with a very good concept. I am all in. This will go to $1/share by December this year.'
Author: annickawaechter yahoofinance
I am already looking forward to the earnings.
Will be worth 3-4 dollars/share if management can realize $100m in annual sales in a couple of years
SeeThruEquity Initiates Coverage on Hooper Holmes Inc. (NYSE MKT: HH) with a Price Target of $0.51
http://finance.yahoo.com/news/seethruequity-initiates-coverage-hooper-holmes-140000481.html
Ok. Normally I do that all the time. Sorry
The government will need to release FnF.
$11Bill Rev/1.16 bill shares X 17 P/E= $161.00 @TheJusticeDept
Of course this doesn’t take into consideration any subsequent PENALTIES
$40/share….perhaps after a 4/1 forward split–warrants are invalid
the biggest variable is what the P/E should be
P/E is variable---floating target===could be a lot higher--like 40
Net income/outstanding shares * P/E multiple==PPS
thus 11/1.16*40===PPS of $379.00
PPS shd be $379.00 $11bill/1.16X P/E 40==$379.00
Excellent news!
Another excellent post.
If I was a Democratic presidential candidate I would ask my party to setlle this as soon as possible, because when this scandal comes out, no way the Democarts are going to win the presidential election.
'NATIONAL REVIEW: Let the Sunshine of Disclosure Disinfect Fannie Mae Litigation
Investors in the mortgage giants deserve a chance to make their case.
March 4, 2016
by *Saikrishna Prakash
In the coming days and weeks, federal judge Margaret Sweeney will rule on a motion to compel the federal government to disclose tens of thousands of documents sought by Fairholme Funds Inc. related to the federal conservatorship of Fannie Mae and Freddie Mac. The government’s attempt to shield these documents via a claim of executive privilege looks absurd, especially since the documents may reveal wrongdoing on the part of the Treasury Department. Let’s hope Judge Sweeney forces the government to turn those documents over.
The suit had its origins in 2008, when the federal government moved to prevent the collapse of the federally chartered enterprises Fannie Mae and Freddie Mac, which buy mortgage loans from banks and bundle them into securities that are sold to investors. This is aimed at helping to keep markets liquid so that banks can make more home loans. That year’s Housing and Economic Recovery Act provided Fannie and Freddie with billions in public funds and placed them in conservatorship under the authority of the newly established Federal Housing Finance Agency (FHFA), but did not eliminate the interests that private shareholders had in Fannie and Freddie. In 2012, when the companies began generating profits again, Treasury Department officials negotiated what has become known as the Net Worth Sweep. The Net Worth Sweep diverts nearly all net income from both enterprises to the Treasury. Thus Fannie and Freddie have sent over $241 billion to the Treasury, leaving Fannie and Freddie shareholders out in the cold.
In 2013 Fairholme Funds filed a federal suit, alleging that the government exceeded its authority and ignored the law’s requirement to conserve the assets of the enterprises. Essentially, Fairholme Funds, Inc., et al. v. United States, et al. alleges that FHFA and the government engaged in illegal takings. The Treasury likely wanted to use the revenues to strengthen its hand in budget negotiations and hoped ultimately to wind down Fannie and Freddie, so the rights of shareholders were apparently an afterthought. The legality of the Sweep and the implications for shareholders, taxpayers, capital markets, and homebuyers have been the subject of several other lawsuits and a contentious debate ever since.
On the narrow issue of documents relevant to the Net Worth Sweep, Judge Sweeney has demonstrated a healthy skepticism regarding the government’s claims that over 77,000 of them must be shielded from public view and that over 11,000 cannot even be shared privately with Fairholme Fund’s lawyers. She’s not alone in voicing doubts about the government’s position. For over a year, the sheer volume of documents for which the government has sought confidential treatment has drawn scrutiny from Senate Judiciary Committee chairman Charles Grassley and numerous media outlets. Judge Sweeney’s ruling on Fairholme’s motion to compel could be pivotal in the litigation and could vindicate the public’s right to learn more about the Sweep and its propriety.
“Executive privilege” traces back to President George Washington and his infrequent decisions to withhold documents from Congress. In modern times, the practice of shielding documents and conversations has ballooned. Courts have allowed presidents to assert confidentiality to ensure they can get candid advice and to protect matters of national security. In the Fairholme case, the government has invoked a variety of privilege claims focusing on the “deliberative process” or the process by which the government makes decisions. This privilege, meant to shield pre-decisional materials, is not absolute and requires a department head to review the supposedly privileged documents and determine that the privilege actually applies. But the government has invoked this privilege in such a sweeping and troubling manner that Judge Sweeney’s intervention is necessary.
For instance, federal officials have not attested that they have reviewed the supposedly privileged documents and that these documents qualify for the privilege. Moreover, the government asserts a privilege over documents shared with FHFA but also asserts that FHFA is not the “United States.” But if FHFA is not the United States, documents shared with it cannot be shielded by the deliberative-process privilege: Sharing pre-decisional documents with entities outside the government waives the privilege, preventing its subsequent invocation.
In invoking executive privilege in such a wholesale way — attempting to keep secret over 10,000 documents — the administration has given yet another black eye to the concept of executive privilege. The courts have instructed that the privilege should be construed narrowly to permit parties “seeking discovery to obtain sufficient information” and that the government bears the burden of establishing that its invocation is valid. The government has not met its burden and has followed its Net Worth Sweep with an Under-the-Rug Document Sweep, one that prevents plaintiffs from seeing documents they need to demonstrate that the Net Worth Sweep is inconsistent with federal law. Judge Sweeney should be guided by the wisdom of Louis Brandeis, who counseled that sunlight was “the best of disinfectants.” The Net Worth Sweep smells like rotting fish, and some cleansing is desperately in order.
___________________________________________________________
*Writer Saikrishna Prakash is the James Monroe Distinguished Professor of Law and Horace W. Goldsmith Research Professor at the University of Virginia School of Law.
Author: bladedoctor01 on yahoofinance
One day:close at $2.02 open at $75common share